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S U M M A R Y
Objective: To understand the seroepidemiology of varicella zoster virus (VZV) in the Singaporean
population, based on a paediatric survey conducted in 2008–2010 and the 2010 National Health Survey.
The ﬁndings were compared with previous studies carried out in 1989–1990, 1993, 1998, and 2004.
Methods: The paediatric survey involved 1200 subjects; residual diagnostic serum samples were
collected from Singapore residents aged 1–17 years at two hospitals. The adult survey involved 3293
subjects; residual serum samples were obtained from Singapore residents aged 18–79 years who had
participated in the 2010 National Health Survey.
Results: The seroprevalence in children under 5 years of age increased from 4% in 1989/1990 to 11.7% in
1998 and 33.2% in 2008–2010. For children aged 5–14 years, the corresponding seroprevalences were
22.8%, 59.5%, and 58.0%. The seroprevalence in children aged 5–14 years in 2008–2010 was not
signiﬁcantly different from that in 1998 (p = 0.721). Among Singapore adults over 25 years of age, the
seroprevalence remained consistently high at around 88% from 1998/1990 to 2010.
Conclusions: Nearly two-thirds of pre-school children, 39.5% of primary school children, and 29% of
adolescents aged 13–17 years are susceptible to VZV infection. At this level of immunity, it can be
expected that outbreaks will continue to occur unless the varicella vaccine is introduced into the
national childhood immunization programme.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Chickenpox, an acute contagious disease caused by primary
infection with the varicella zoster virus (VZV), is highly endemic in
Singapore, with periodic outbreaks occurring in childcare centres,
kindergartens, schools, and other educational institutions.1,2 The
disease is reported throughout the year, with no deﬁnite seasonal
pattern. The reported annual incidence rate per 100 000 popula-
tion increased from 51.9 in 1982 to 636.1 in 1989, and reached a
peak of 1355.7 in 1996. This increase could have been due in part to
better disease notiﬁcation, but it has also been attributed to closely
related VZV genotypes infecting a highly susceptible population.3
Thereafter, there was a general downward trend, with the
incidence per 100 000 population being between 371.0 and
665.7 during the period 2002–2007. It is not known whether or       
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contributed to this declining trend.
The disease has occurred most commonly in older children and
young adults aged 5 to 24 years. This is in contrast to temperate
countries where the disease incidence is highest in children aged 5
to 9 years.4–6 However, from 1998 onwards, the highest age-
speciﬁc incidence rate was recorded in children less than 5 years of
age. Among the three major ethnic groups, Malays consistently had
a higher incidence rate compared to Chinese and Indians. The
male-to-female ratio ranged from 1.2:1 to 2.6:1 during the period
1998–2006.
Mortality due to chickenpox has consistently been low. From
1992 to 2011, there were 46 deaths due to chickenpox, mainly
among adults and the elderly, either as the primary cause of death
or as a contributory cause. Varicella pneumonia was not only the
most common complication, but also caused the highest mortality.
Other reported causes of death secondary to chickenpox included
disseminated intravascular coagulation, myocarditis, nephritis,
septicaemia, and encephalitis.7–10
A serological survey conducted in 1989–1990 showed an
overall prevalence of 42.8% among healthy children and adults,
aged 6 months to over 45 years, with less than 20% of children agedociety for Infectious Diseases. Open access under CC BY-NC-ND license.
Table 1
Age-speciﬁc seroprevalence (%) of VZV infection by gender and ethnic group in
children aged 1–17 years, 2008–2010
Demographics Age group
1–6 years
(n = 400)
7–12 years
(n = 400)
13–17 years
(n = 400)
1–17 years
(n = 1200)
All 34.5 60.5 71.0 55.3
Gender
Male 36.0 64.0 67.9 54.1
Female 32.6 57.0 73.0 56.5
Ethnic group
Chinese 38.9 61.4 75.0 58.0
Malay 24.2 63.4 62.5 49.8
Indian 30.0 45.5 69.6 51.2
VZV, varicella zoster virus.
N. Fatha et al. / International Journal of Infectious Diseases 22 (2014) 73–7774under 15 years possessing antibody to VZV. The prevalence in
those over 25 years of age was between 86% and 98%.11 Several
other seroprevalence studies on VZV infection were carried out in
subsequent years.12–14 We undertook another national seropreva-
lence study in children and adolescents aged 1–17 years between
2008 and 2010, and of adults aged 18 years and above using serum
samples from the 2010 National Health Survey, to determine the
changing seroprevalence of VZV infection in Singapore.
2. Materials and methods
The national paediatric seroprevalence survey was carried out in
accordance with Section 7 of the Infectious Diseases Act, which
allows residual blood samples to be used for public health
surveillance. Residual serum samples were obtained from Singapore
citizens and permanent residents of the three major ethnic groups
(Chinese, Malay, and Indian) aged 1–17 years attending inpatient
services and day surgeries at the two large public hospitals (Kandang
Kerbau Women’s and Children’s Hospital (KKH) and the National
University Hospital). Serum from patients known to be immuno-
compromised or on immunosuppressive drugs, or who had been
diagnosed with childhood infectious diseases such as measles,
mumps, rubella, and chickenpox, were excluded.
On the premise of an anticipated seropositivity rate of at least
30% in each of the age groups 1–6, 7–12, and 13–17 years, the
minimum sample size required for each age group was 323, with a
conﬁdence level of 95% and an absolute precision of 5% points. We
adopted a sample size of 1200, comprising 400 in each of the three
age groups. Vaccination records of the subjects were obtained from
the National Immunisation Registry and the School Health Service,
Health Promotion Board.
For the adult population, residual serum samples were obtained
from the 2010 National Health Survey. The National Health Survey
is a 6-yearly cross-sectional study conducted to determine the
prevalence of major non-communicable diseases and their
associated risk factors among the residents of Singapore. The
study population was selected by a combination of disproportion-
ate stratiﬁed sampling and systematic sampling.15 The survey
sample data were adjusted to the age, ethnic group, and gender
distribution of the Singapore resident population in 2010 so as to
ensure that the characteristics of the samples conformed to those
of the general population. A total of 3293 residual samples from
Singapore residents aged 18 to 79 years were collected. The
participants had consented to having their residual serum used for
further research. Personal identiﬁers were permanently removed
and new survey numbers were assigned before they were sent to
the testing laboratories. This process of delinking was to ensure
strict anonymity for the study participants. Approval was obtained
from the Institutional Review Board Ethics Committee of the
Health Promotion Board.
Residual serum samples were tested for IgG antibody against VZV
by enzyme immunoassay (EIA; EUROIMMUN AG, Germany); levels
100 mIU/ml were considered to indicate evidence of past natural
infection or vaccination against VZV. The Chi-square test with Yates’
continuity correction was used to test for signiﬁcance of the
difference between proportions. The Mantel–Haenszel linear-by-
linear association Chi-square test was used to evaluate whether there
was a linear trend in seroprevalence among the age groups for each
survey. The statistical analysis was performed using the statistical
software package, PASW Statistics version 18.0 (SPSS Inc., Chicago, IL,
USA). A p-value of <0.05 was considered statistically signiﬁcant.
3. Results
The overall VZV seroprevalence among children and adoles-
cents aged 1–17 years was 55.3% (95% conﬁdence interval (CI)52.5–58.1%). Only 8.7% of the subjects had received one dose of
varicella vaccine prior to the collection of blood samples.
Seroprevalence was lowest at 34.5% (95% CI 30.0–39.3%) in
children aged 1–6 years, increasing signiﬁcantly to 60.5% (95%
CI 55.6–65.2%) in 7–12-year-olds and to 71.0% (95% CI 66.4–75.2%)
in 13–17-year-olds (p < 0.001) (Table 1).
The seroprevalence was between 27.9% and 45.3% in the 1–7
years age group, and subsequently increased from 52.1% in
children aged 8 years to 83.3% in adolescents aged 17 years
(Figure 1). There was no signiﬁcant difference in the seropreva-
lence by gender (54.1% in males vs. 56.5% in females; p = 0.406).
The seroprevalence in the Chinese (58.0%) was signiﬁcantly higher
than in the Malays (p = 0.018), while it was similar to that of
Indians (p = 0.147). There was no statistically signiﬁcant difference
in the seroprevalence between Malays (49.8%) and Indians (51.2%)
(p = 0.801). The seropositivity rate among those vaccinated (59.6%)
was not signiﬁcantly different from those with an unknown
vaccination status or no vaccination records (56.1%) (p = 0.486).
Among the adult population, the prevalence was between 84.0%
in the youngest age group of 18–29 years and 96.4% in the oldest
age group of 70–79 years (data not shown). There was no
signiﬁcant difference by gender (90.3% in males vs. 90.7% in
females; p = 0.68). There was a signiﬁcant difference in the
seroprevalence among the three main ethnic groups
(p < 0.0005). The seroprevalence in the Chinese (91.0%) and
Malays (91.9%) was quite similar (p = 0.55), but signiﬁcantly
higher than that in the Indians (83.5%) (p < 0.0005).
To determine the changing seroepidemiology of VZV infection,
we compared the ﬁndings with those obtained from previous
serological surveys carried out in 1989/1990, 1993, 1998, and
2004.12–14 For the adult population in 2004, the seroprevalence was
determined using residual sera from the 2004 National Health
Survey16 (Ministry of Health, Singapore, unpublished data). The age-
speciﬁc seroprevalence of VZV infection found in the various surveys
is depicted in Figure 2. There was a linear trend in seroprevalence by
speciﬁc 5-year age groups in ﬁve surveys (all p < 0.05), except in
2004 (18–74 years) (p = 0.690). In the 1989/1990 survey, only 4% of
children below 5 years of age were seropositive. The seropositivity
rate increased with age, with the sharpest increase seen in the 20–24
years (50% seropositive) and 25–34 years age groups (86–98%
positive).12,13 In the 1993 survey, the overall seropositivity was
60.2%; the prevalence was 24.8% in children aged under 15 years,
increasing to 51.3% in the 15–24 years group and 83.3% in the 25–34
years age group, with the majority of the population over 35 years of
age being seropositive (87.9%).13 In the 1998 survey, the overall
seroprevalence had increased to 58.1%, with 11.7% of children under
5 years of age being seropositive. It then increased sharply to 77.4%
in the 10–14 years, 69.3% in the 15–24 years, and 80.5% in the 25–34
years age groups.14 The ﬁndings among the adult population in 2004
and 2010 were very similar.
Figure 1. Seroprevalence (%) of varicella zoster virus infection by age in children aged 1–17 years, 2008–2010 (bars indicate the 95% conﬁdence interval).
Figure 2. Age-speciﬁc seroprevalence of varicella zoster virus infection in the Singapore resident population, 1989–2010.
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Our seroepidemiological ﬁndings are similar to those of other
tropical countries in the region, such as Malaysia, Philippines,
Thailand, and India, where seroconversion against VZV generally
occurs in late adolescence and adulthood.17–24 In temperate
countries, virtually all seroconversion occurs by late childhood,
with between 90% and 100% of the population in North America,
Western Europe, New Zealand, and Japan seropositive by 15 years
of age.25–31 In New Zealand, the prevalence of VZV infection in
2009 was 87.3% in children aged 6–10 years and 94.4% in the age
group 11–15 years.32 The corresponding prevalences for the same
age groups in Singapore children in 2008–2010 were 50.8% and
67.6%, respectively. Among Singapore adults over 25 years of age,
the seroprevalence remained consistently high at around 88% from
1998/1990 to 2010.
The lower seroprevalence in Indians may be a reﬂection of the
lower incidence of varicella in the Indian community. Of the three
major ethnic groups, the Indian community was found to have the
lowest chickenpox incidence, whilst the Malays were found to
have the highest incidence.2 In a study carried out on male nationalservicemen, a signiﬁcantly smaller proportion of Indians reported a
history of varicella infection compared to Chinese and Malays.33
The higher level of chickenpox incidence and subsequently
seroprevalence in Malays may be attributed to household size,
as Malays have the largest household size. However, this does not
explain the differences in seroprevalence between Chinese and
Indians, who have similar household sizes.34 Further studies on the
ethnic differences in varicella incidence and seroprevalence in the
Singaporean population are required.
A number of reasons have been proposed for the difference in
the seroepidemiology of VZV infection between countries in the
tropics and temperate regions. The lower seroprevalence among
children in the tropics has been attributed to high ambient
temperature and humidity.35–37 The higher levels of ultraviolet
radiation in the tropics has also been postulated to inactivate the
VZV virus, leading to the different patterns of infection.38 More
studies examining the inﬂuence of temperature on the VZV virus,
and studies comparing the temperature required to inactivate VZV
to the temperature needed to inactivate other viruses are required
to gain a better understanding of the differences in seroepidemiol-
ogy in the two climates.
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of VZV, herpes simplex virus (HSV), Epstein–Barr virus (EBV), and
cytomegalovirus (CMV) infections in Singapore based on surveys
conducted from 1989 to 1993, we found that while the pattern for
VZV and HSV infections was very similar, it was different from that
of CMV and EBV infections; in the latter, seroconversion occurred
at an earlier age, with a seropositivity rate of between 40% and 60%
in preschool children under 5 years of age compared to 5–10% in
the case of VZV and HSV infections.39 The reason for this difference
remains unclear. HSV is most closely related to VZV. The similar
pattern of infections of the two viruses may be due to cross-
immunity, as there has been evidence of cross-antigenicity
between HSV and VZV.40–42
We note that among the child population, the seroprevalence
has increased over the last 20 years. The seroprevalence in
preschool children under 5 years of age increased almost three
times from 4% in 1989/1990 to 11.7% in 1998, and to 33.2% in
2008–2010. For children aged 5–14 years, the corresponding
ﬁgures are 22.8%, 59.5%, and 58.0%, respectively. The seropreva-
lence in children 5–14 years of age in 2008–2010 was not
signiﬁcantly different from that in 1998 (p = 0.721).
There are several reasons that could account for this trend. First,
the VZV vaccine was licensed for use in Singapore in 1996. A survey
conducted 2 years after varicella vaccine licensure showed a
marked increase in seroprevalence in children under 15 years of
age. Although vaccination against chickenpox has not been
introduced into the national childhood immunization programme,
it is readily available at public hospitals, government clinics, and
private medical practices on an individual basis, and more and
more parents are having their children vaccinated. Data from the
National Immunisation Registry, Health Promotion Board, show a
general increasing trend in the number of children aged 1–2 years
who have been vaccinated with at least one dose of varicella-
containing vaccine; the coverage rate ranged from 24.3% in 2006 to
52.0% in 2010.
The higher seroprevalence in the child population could also be
due to the changing epidemiology of natural infection with higher
transmission among susceptible children in preschool centres.
During the period 1985–1990, the age-speciﬁc incidence of
reported chickenpox cases was highest in the 15–24 years age
group. It was highest in the 5–14 years age group from 1990 to
1993.43 However, since 1996, the highest incidence has shifted to
preschool children under 5 years of age. The incidence in this age
group increased from 1991 per 100 000 population in 2004 to 2875
per 100 000 population in 2007. This could be attributed in part to
the sharp demand for infant care, childcare, and student care
centres in recent years. In 2003, there were 653 childcare centres
for 54 000 children and this increased to 1083 centres for 101 600
children in 2013.44,45
The child population in Singapore remains highly susceptible to
VZV infection. Nearly two-thirds of children aged 1–6 years and
39.5% of primary school children did not possess antibody against
VZV. Among adolescents aged 13–17 years, 29% were susceptible
to VZV infection. With this level of immunity, institutional
outbreaks of chickenpox will continue to occur unless the varicella
vaccine is introduced into the national childhood immunization
programme. In the USA, the successful implementation of the
childhood varicella vaccination programme, with vaccine coverage
of 87%, has successfully brought the disease under control.46 In
Beijing, China, varicella vaccine is available for private purchase
and is also administered in schools in response to institutional
outbreaks. The incidence of chickenpox in children 1–4 years of age
decreased signiﬁcantly after vaccination was made available.47
In Singapore, a cost–beneﬁt study based on 1994–1995 data
showed that if varicella vaccine were added to the national
childhood immunization programme, US$ 2 would be saved forevery dollar invested, from the societal point of view.48 It would be
timely to review the inclusion of the vaccine in the national
childhood immunization programme based on an updated cost–
beneﬁt analysis. Alternatively, a targeted approach such as that
carried out in China may be warranted; although being a small
country, Singapore will not have problems in achieving complete
geographical coverage.
One major limitation of the study is that the ﬁndings of the
various surveys may not be directly comparable due to different
study designs. The 1989/1990 survey was based on serum obtained
from healthy infants and children at routine health assessments at
the postnatal clinic of KKH. For adults, women attending
government antenatal clinics and blood donors from the National
Blood Centre were recruited. For the 1993 and 1998 surveys, blood
samples were collected from healthy children and adults, aged
between 6 months and over 45 years, at designated government
polyclinics following publicity regarding the national serological
studies. For the 2004 National Health Survey, blood samples were
obtained from adults aged 18-74 years. For the 2010 National
Health Survey, blood samples were obtained from adults aged 18-
79 years. Another limitation is the use of different commercial test
kits and cut-off values for seropositivity. Enzyme immunoassays
were used in all these texts and we believe that the sensitivity and
speciﬁcity are comparable.
Acknowledgements
We would like to thank the staff members of the diagnostic
laboratories of Kandang Kerbau Women’s and Children’s Hospital
and the National University Hospital, Singapore, for their support
and cooperation in the collection of residual serum for the National
Paediatric Seroprevalence Survey 2008–2010.
Conﬂict of interest: The authors have no conﬂicts of interest
(ﬁnancial or non-ﬁnancial) to declare.
References
1. Quarantine and Epidemiology Department. Communicable disease surveillance
in Singapore 1990–2002. Singapore: Ministry of the Environment; 1991-2003.
2. Ministry of Health. Communicable Disease Surveillance in Singapore 2003-
2006. Singapore: Ministry of Health; 2004-2007
3. Chow VT, Wan SS, Doraisingam S, Ling AE. Comparative analysis of the restric-
tion endonuclease proﬁles of the Dumas and Singapore strains of the varicella
zoster virus. J Med Virol 1993;40:339–42.
4. Nardone A, de Oryb F, Carton M, Cohend D, van Dammee P, Davidkin I, et al. The
comparative sero-epidemiology of varicella zoster virus in 11 countries in the
European region. Vaccine 2007;25:7866–72.
5. Koskiniemi M, Lappalainen M, Schmid DS, Rubtcova E, Loparev VN. Genotypic
analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine
Immunol 2007;14:1057–61.
6. van Rijckevorsel G, Damen M, Sonder GJ, van der Loeff MF, van den Hoek A.
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the
Amsterdam adult population. BMC Infect Dis 2012;12:140–7.
7. Lam MS, Chew SK, Allen DM, Monteiro EH. Fatal varicella infections in
Singapore. Singapore Med J 1993;34:213–5.
8. Phuah HK, Chong CY, Lim KW, Cheng HK. Complicated varicella zoster infection in
8 paediatric patients and review of literature. Singapore Med J 1998;39:115–20.
9. Nathan S, Pang AS, Singh Sidhu D, Lam KS, Low JM. Necrotising soft tissue
infections as a complication of chickenpox. Singapore Med J 1995;36:656–60.
10. Tan CB, Chitra M, Tjia TL, Lee BW. Central nervous system manifestations of
chicken pox—a report of two cases. Singapore Med J 1985;26:386–8.
11. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus
infection in Singapore. Southeast Asian J Trop Med Public Health 1992;23:22–5.
12. Ministry of Health, Singapore. Prevalence of antibody to varicella-zoster virus.
Epidemiological News Bulletin 1990;16:53–4.
13. Ministry of Health, Singapore. Epidemiological surveillance of varicella-zoster
virus infection in Singapore. Epidemiological News Bulletin 1996;22:61–4.
14. Ministry of Health, Singapore. Seroprevalence of varicella-zoster virus infection
in Singapore. Epidemiological News Bulletin 2000;26:59-62.
15. Ministry of Health, Singapore. National Health Survey 2010. http://www.moh.-
gov.sg/content/dam/moh_web/Publications/Reports/2011/NHS2010%20-
%20low%20res.pdf published Nov 2011. (accessed 14 May 2013).
16. Ministry of Health, Singapore. National Health Survey 2004. http://www.moh.-
gov.sg/content/moh_web/home/Publications/Reports/2005/national_health_-
survey2004.html published Oct 2005. (accessed 24 Mar 2014).
N. Fatha et al. / International Journal of Infectious Diseases 22 (2014) 73–77 7717. Barzaga NG, Roxas JR, Florese RH. Varicella zoster virus prevalence in metro
Manila, Philippines. JAMA (SE Asia) 1994;274:S633–5.
18. Bhattarakosol P, Chantarabul S, Pittayathikhun K, Mung-mee V, Punnarugsa V.
Prevalence of anti-varicella zoster IgG antibody in undergraduate students. Asia
Pac J Allergy Immunol 1996;14:129–31.
19. Kositanont U, Wasi C, Oonsombat P, Suvatte V, Thongcharoen P. Susceptibility
to varicella zoster virus in Thai children and young adults. Southeast Asian J Trop
Med Public Health 1985;16:414–20.
20. Malik YA, Baharin R. Prevalence of varicella zoster virus infection in Malaysia.
In: Proceedings of the 5th International Congress on the Impact of Viral
Diseases in the Developing World, 1995. South Africa: Johannesburg; 1995.
21. Migasena S, Simasathien S, Desakorn V, Phonrat B, Suntharasamai P, Pitisutti-
tham P, et al. Seroprevalence of varicella zoster virus antibody in Thailand. Int J
Infect Dis 1997;2:26–30.
22. Ministry of Public Health, Bangkok. Annual epidemiological surveillance report
1995. Thailand: Ministry of Public Health; 1995.
23. Nassar NT, Touma HC. Brief report: Susceptibility of Filipino nurses to the
varicella zoster virus. Infect Control 1986;7:71–2.
24. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast
Asia. Trop Med Int Health 1998;3:886–90.
25. Preblud SR. Age-speciﬁc risks of varicella complications. Pediatrics 1981;68:
14–7.
26. Muench R, Nassim C, Niku S, Sullivan-Bolyai JZ. Seroepidemiology of varicella. J
Infect Dis 1986;153:153–5.
27. Wharton M. The epidemiology of varicella zoster virus infections. Infect Dis Clin
North Am 1996;10:571–81.
28. Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and
varicella infection among young adults: a serosurvey of US Navy and Marine
Corps recruits. Am J Public Health 1993;83:17–20.
29. Fairley CK, Miller E. Varicella zoster virus epidemiology—a changing scene? J
Infect Dis 1996;174(Suppl 3):S314–9.
30. Eguiluz GC, Trallero EP, Arenzana JM. Seroepidemiology of varicella in children
from Spain. J Infect Dis 1987;156:851.
31. Taylor-Wiedeman J, Yamashita K, Miyamura K, Yamazaki S. Varicella zoster
virus prevalence in Japan: no signiﬁcant change in a decade. Jpn J Med Sci Biol
1989;42:1–11.
32. Weir R, Jennings L, Young S, Brunton C, Murdoch D. National serosurvey of
vaccine preventable diseases. Wellington, New Zealand: Ministry of Health;
2009.
33. Dashraath P, Ong ES, Lee VJ. Seroepidemiology of varicella and the reliability of
a self-reported history of varicella infection in Singapore military recruits. Ann
Acad Med Singapore 2007;36:636–41.34. Department of Statistics, Ministry of Trade and Industry, Singapore. Census of
Population 2010 Statistical Release 2: Households and Housing. http://
www.singstat.gov.sg/publications/publications_and_papers/cop2010/cen-
sus_2010_release2/cop2010sr2. pdf published Feb 2011. (accessed 14 May
2013).
35. Garnett GP, Cox MJ, Bundy DA, Didier JM, St Catharine J. The age in infection
with varicella zoster virus in St Lucia, West Indies. Epidemiol Infect
1993;110:361–72.
36. Chang CK, Tan HF, Tseng HF, Lin CC. Analysis of factors associated with
varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
Med Mal Infect 2007;37:222–8.
37. Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT,
et al. Seroprevalence of varicella zoster virus infections in Colombo district, Sri
Lanka. Indian J Med Sci 2007;61:128–34.
38. Rice PS. Ultra-violet radiation is responsible for the differences in global
epidemiology of chickenpox and the evolution of varicella-zoster virus as
man migrated out of Africa. Virol J 2011;8:189.
39. Ministry of Health. Seroprevalence of Epstein–Barr virus infection in Singapore.
Epidemiological News Bulletin 1996;22:1–3.
40. Kapsenberg JG. Possible antigenic relationship between varicella-zoster virus
and herpes-simplex virus. Arch Ges Virusforsch 1964;15:67–73.
41. Ross CA, Sharpe JH, Ferry P. Antigenic relationship of varicella-zoster virus and
herpes-simplex. Lancet 1965;286:708–11.
42. Edson CM, Hosler BA, Respass RA, Waters DJ, Thornley-Lawson DA. Cross-
reactivity between herpes-simplex virus glycoprotein B and a 63 000 Dalton
varicella-zoster virus envelope glycoprotein. J Virol 1985;56:333–6.
43. World Health Organization. Wkly Epidemiol Rec 1992;67(16):113-120.
44. Ministry of Community Development and Sports, Singapore. Singapore social
statistics in brief 2004; Available at: http://unpan1.un.org/intradoc/groups/
public/documents/APCITY/UNPAN024574.pdf published 2004 (accessed May
14, 2013).
45. Early Childhood Development Agency, Singapore. Statistics on childcare ser-
vices; Available at: http://www.childcarelink.gov.sg/ccls/uploads/Statistic-
s_on_child_care%28STENT%29.pdf published Jan 2014 (accessed Mar 2014).
46. Luman ET, Ching PL, Jumaan AO, Seward JF. Uptake of varicella vaccination
among young children in the United States: a success story in eliminating racial
and ethnic disparities. Pediatrics 2006;117:999–1008.
47. Lu L, Wang C, Suo L, Li J, Liu W, Pang X, et al. Varicella disease in Beijing in the era
of voluntary vaccination, 2007–2010. Pediatr Infect Dis J 2013;32:e314–8.
48. Lee ML, Shek LP, Ma S, Chew SK, Chew FT, Lee BW. Economic burden of varicella
in Singapore—a cost beneﬁt estimate of implementation of a routine varicella
vaccination. Southeast Asian J Trop Med Public Health 2004;35:693–6.
